Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model

Nanotoxicology

Volumn 7, Issue 7, 2013, Pages 1198-1210

  Walczak, Agata P ^a   Fokkink, Remco ^a   Peters, Ruud ^a   Tromp, Peter ^b   Herrera Rivera, Zahira E ^a   Rietjens, Ivonne M C M ^a   Hendriksen, Peter J M ^a   Bouwmeester, Hans ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Characterisation; Gastric; Ingestion; Intestinal; Oral

Indexed keywords

CHLORINE; PROTEIN; SILVER NANOPARTICLE; SILVER NITRATE; WATER;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIGESTION; GASTROINTESTINAL SECRETION; HUMAN; IN VITRO STUDY; INTESTINE WALL; LIGHT SCATTERING; MASS SPECTROMETRY; MOLECULAR SIZE; PRIORITY JOURNAL; SALIVA; SCANNING ELECTRON MICROSCOPY; STOMACH JUICE; X RAY ANALYSIS;

DIGESTION; GASTRIC JUICE; HUMANS; INTESTINAL SECRETIONS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; MODELS, BIOLOGICAL; PARTICLE SIZE; SALIVA; SILVER; SILVER NITRATE; SURFACE PROPERTIES;

EID: 84883495773     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2012.726382     Document Type: Article

References (43)

1. Allahverdiyev AM, Kon KV, Abamor ES, Bagirova M, Rafailovich M. 2011. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther 9:1035-1052.
2. Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, et al. 2008. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol 5:14.
3. Bouwmeester H, Dekkers S, Noordam MY, Hagens WI, Bulder AS, de Heer C, et al. 2009. Review of health safety aspects of nanotechnologies in food production. Regul Toxicol Pharm 53:52-62.
4. Brandon EF, Oomen AG, Rompelberg CJ, Versantvoort CH, van Engelen JG, Sips AJ. 2006. Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment. Regul Toxicol Pharmacol 44:161-171.
5. Cedervall T, Lynch I, Foy M, Berggard T, Donnelly SC, Cagney G, et al. 2007. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl 46:5754-5756.
6. Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L, et al. 2008. Applications and implications of nanotechnologies for the food sector. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25:241-258.
7. Chen X, Schluesener HJ. 2008. Nanosilver: a nanoproduct in medical application. Toxicol Lett 176:1-12.
8. Cheng D, Xia H, Chan HS. 2004. Facile fabrication of AgCl@polypyrrole- chitosan core-shell nanoparticles and polymeric hollow nanospheres. Langmuir 20:9909-9912.
9. Choi O, Clevenger TE, Deng B, Surampalli RY, Ross L Jr, Hu Z. 2009. Role of sulfide and ligand strength in controlling nanosilver toxicity. Water Res 43:1879-1886.
10. Danscher G, Stoltenberg M. 2006. Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog Histochem Cytochem 41:57-139.
11. Drake PL, Hazelwood KJ. 2005. Exposure-related health effects of silver and silver compounds: a review. Ann Occup Hyg 49:575-585.
12. EFSA, Committee ES. 2011. Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA J 9:36.
13. El Badawy AM, Luxton TP, Silva RG, Scheckel KG, Suidan MT, Tolaymat TM. 2010. Impact of environmental conditions (pH, ionic strength, and electrolyte type) on the surface charge and aggregation of silver nanoparticles suspensions. Environ Sci Technol 44:1260-1266.
14. Fabrega J, Fawcett SR, Renshaw JC, Lead JR. 2009. Silver nanoparticle impact on bacterial growth: effect of pH, concentration, and organic matter. Environ Sci Technol 43:7285-7290.
15. Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. 2009. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 190:156-162.
16. Greulich C, Kittler S, Epple M, Muhr G, Koller M. 2009. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg 394:495-502.
17. Huynh KA, Chen KL. 2011. Aggregation kinetics of citrate and polyvinylpyrrolidone coated silver nanoparticles in monovalent and divalent electrolyte solutions. Environ Sci Technol 45:5564-5571.
18. Jonas L, Bloch C, Zimmermann R, Stadie V, Gross GE, Schad SG. 2007. Detection of silver sulfide deposits in the skin of patients with argyria after long-term use of silver-containing drugs. Ultrastruct Pathol 31:379-384.
19. Kittler S, Greulich C, Diendorf J, Koller M, Epple M. 2010. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater 22:4548-4554.
20. Laborda F, Jimenez-Lamana J, Bolea E, Castillo JR. 2011. Selective identification, characterization and determination of dissolved silver(I) and silver nanoparticles based on single particle detection by inductively coupled plasma mass spectrometry. J Anal Atom Spectrom 26:1362-1371.
21. Levard C, Reinsch BC, Michel FM, Oumahi C, Lowry GV, Brown GE. 2011. Sulfidation processes of PVP-coated silver nanoparticles in aqueous solution: impact on dissolution rate. Environ Sci Technol 45:5260-5266.
22. Li L, Zhu YJ. 2006. High chemical reactivity of silver nanoparticles toward hydrochloric acid. J Colloid Interface Sci 303:415-418.
23. Li X, Lenhart JJ, Walker HW. 2010. Dissolution-accompanied aggregation kinetics of silver nanoparticles. Langmuir 26:16690-16698.
24. Liu J, Hurt RH. 2010. Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ Sci Technol 44:2169-2175.
25. LoeschnerK,HadrupN,Qvortrup K, Larsen A,Gao X, VogelU, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18.
26. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265-14270.
27. Lynch I, Dawson KA2008.Protein-nanoparticle Interactions. Nano Today 3 40-47.
28. Meziani MJ, Sun YP. 2003. Protein-conjugated nanoparticles from rapid expansion of supercritical fluid solution into aqueous solution. J Am Chem Soc 125:8015-8018.
29. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239-253.
30. Nanoparticle Products Inventory, PEN. http://www.nanotechproject.org
31. Nath N, Chilkoti A. 2004. Label-free biosensing by surface plasmon resonance of nanoparticles on glass: optimization of nanoparticle size. Anal Chem 76:5370-5378.
32. Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, et al. 2008. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 42:8959-8964.
33. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8.
34. Oomen AG, Tolls J, Sips AJAM, Van den Hoop MAGT. 2003. Lead speciation in artificial human digestive fluid. Arch Environ Contam Toxicol 44:107-115.
35. Pace HE, Rogers NJ, Jarolimek C, Coleman VA, Higgins CP, Ranville JF. 2011. Determining transport efficiency for the purpose of counting and sizing nanoparticles via single particle inductively coupled plasma mass spectrometry. Anal Chem 83:9361-9369.
36. Peters R, Kramer E, Oomen AG, Herrera Rivera ZE, Oegema G, Tromp PC, et al. 2012. Presence of nano-sized silica during in vitro digestion of foods containing silica as a food additive. ACS Nano 6(3):2441-2451.
37. Rai M, Yadav A, Gade A. 2009. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76-83.
38. Rogers KR, Bradham K, Tolaymat T, Thomas DJ, Hartmann T, Ma L, et al. 2012. Alterations in physical state of silver nanoparticles exposed to synthetic human stomach fluid. Sci Total Environ 420:334-339.
39. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, et al. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452-461.
40. Tien DC, Tseng KH, Liao CY, Tsung TT. 2008. Colloidal silver fabrication using the spark discharge system and its antimicrobial effect on Staphylococcus aureus. Med Eng Phys 30:948-952.
41. Versantvoort CH, Oomen AG, Van de Kamp E, Rompelberg CJ, Sips AJ. 2005. Applicability of an in vitro digestion model in assessing the bioaccessibility of mycotoxins from food. Food Chem Toxicol 43:31-40.
42. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. 2010. What the cell "Sees" in bionanoscience. J Am Chem Soc 132:5761-5768.
43. Zelyanskii AV, Zhukova LV, Kitaev GA. 2001. Solubility of AgCl and AgBr in HCl and HBr. Inorg Mater 37:523-526.